HADV / Health Advance Inc. - SEC-Einreichungen, Jahresbericht, Proxy Statement

HEALTH ADVANCE, INC. SUBSCRIPTION AGREEMENT REGULATION A SHARES

HEALTH ADVANCE, INC. SUBSCRIPTION AGREEMENT REGULATION A SHARES THIS SUBSCRIPTION AGREEMENT made as of the day of , 2022, between HEALTH ADVANCE, INC., a corporation organized under the laws of the State of Wyoming, (the “Company”), and the undersigned (the “Subscriber” and together with each of the other subscribers in the Offering (defined below), the “Subscribers”). WHEREAS, the Company desires

OFFERING CIRCULAR SUPPLEMENT NO. 1 Date of Qualification of the Offering Circular: April 19, 2022 Health Advance, Inc. 9131 Keele Street Suite A4 Vaughan, Ontario, Canada L4K 0G7 April 19, 2022

253G1 1 ha253g1.htm FORM 253G1 Filed Pursuant to Rule 253(g)(1) Offering File Number: 024-11764 OFFERING CIRCULAR SUPPLEMENT NO. 1 Date of Qualification of the Offering Circular: April 19, 2022 Health Advance, Inc. 9131 Keele Street Suite A4 Vaughan, Ontario, Canada L4K 0G7 April 19, 2022 This document (the “Supplement”) supplements the Offering Statement filed on Form 1-A of Health Advance, Inc.

CORPORATE SERVICES AGREEMENT

CORPORATE SERVICES AGREEMENT This Corporate Services Agreement (the “Agreement) is made and effective as of this day of December 2021 (the “Effective Date”), by and between J.

HEALTH ADVANCE, INC. 9131 KEELE STREET, SUITE A4 VAUGHAN, ONTARIO, CANADA L4K 0G7 APRIL 14, 2022

CORRESP 1 filename1.htm HEALTH ADVANCE, INC. 9131 KEELE STREET, SUITE A4 VAUGHAN, ONTARIO, CANADA L4K 0G7 APRIL 14, 2022 VIA EDGAR Attorney Nicholas Lamparski Division of Corporation Finance Office of Trade and Services U.S. Securities and Exchange Commission Re: Health Advance, Inc. Form 1-A: Request for Qualification File No. 024-11764 Dear Mr. Lamparski: Health Advance, Inc. (the “Company”), he

HEALTH ADVANCE, INC. 9131 Keele Street, Suite A4 Vaughan, Ontario, Canada L4K 0G7

HEALTH ADVANCE, INC. 9131 Keele Street, Suite A4 Vaughan, Ontario, Canada L4K 0G7 February 9, 2022 Attorney Nicholas Lamparski Division of Corporation Finance Office of Trade and Services Securities and Exchange Commission Re: Health Advance Inc. Offering Statement on Form 1-A Filed January 3, 2022 File No. 024-11764 Dear Mr. Lamparski: In response to your letter dated January 3, 2022, the followi

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 1-A /A (Amendment No. 1) Dated: February 11, 2022 REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact name of issuer as specified in its charter)

SEC File No. 024-11764 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 1-A /A (Amendment No. 1) Dated: February 11, 2022 REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact name of issuer as specified in its charter) Wyoming (State of other jurisdiction of incorporation or organization) 9131 Keele Street Suite A4 Vaughan, Ontario, Canada L4K

LETTER

United States securities and exchange commission logo January 10, 2022 Larry McLachlin President Health Advance Inc.

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 1-A Dated: December 30, 2021 REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact name of issuer as specified in its charter) Wyoming (State of ot

SEC File No. 000- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 1-A Dated: December 30, 2021 REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact name of issuer as specified in its charter) Wyoming (State of other jurisdiction of incorporation or organization) 9131 Keele Street Suite A4 Vaughan, Ontario, Canada L4K 0G7 (705) 733-7098 (Addre

Jeffrey Turner – Attorney at Law 897 Baxter Drive So. Jordan, Utah 84095 (801) 810-4465 Admitted in the State of Utah

OPINION OF COUNSEL Exhibit 12.01 Jeffrey Turner – Attorney at Law 897 Baxter Drive So. Jordan, Utah 84095 (801) 810-4465 Admitted in the State of Utah December 30, 2021 Larry McLachlin Chief Executive Officer Health Advance, Inc. 9131 Keele Street Suite A4 Vaughan, Ontario, Canada L4K 0G7 Dear Mr. Matthews: I have acted, at your request, as special counsel to XCPCNL Business Services Corporation,

CORPORATE SERVICES AGREEMENT

CORPORATE SERVICES AGREEMENT CORPORATE SERVICES AGREEMENT This Corporate Services Agreement (the “Agreement) is made and effective as of this day of December 2021 (the “Effective Date”), by and between J.

HEALTH ADVANCE, INC. SUBSCRIPTION AGREEMENT REGULATION A SHARES

SUBSCRIPTION AGREEMENT HEALTH ADVANCE, INC. SUBSCRIPTION AGREEMENT REGULATION A SHARES THIS SUBSCRIPTION AGREEMENT made as of the day of , 2022, between HEALTH ADVANCE, INC., a corporation organized under the laws of the State of Wyoming, (the “Company”), and the undersigned (the “Subscriber” and together with each of the other subscribers in the Offering (defined below), the “Subscribers”). WHERE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 333-177122 HEALTH ADVANCE, INC (Exact name of registrant as specified in it

HADV / Health Advance Inc NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response...2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2017 ?

HADV / Health Advance Inc NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response...2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2017 ?

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2018 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission Fi

Board Resolution - June 6, 2017

Exhibit 99.2

Board Resolution - December 12, 2017

Exhibit 99.4

Board Resolution - June 30, 2017

EX-99.3 6 hadvex99z3.htm EXHIBIT 99.3 Exhibit 99.3

Quarterly Report - HEALTH ADVANCE INC. - FORM 10-Q SEC FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE

Letter of Resignation Undersigned by Jordan Starkman - November 1, 2017

jordan starkman resignation letter.tif Exhibit 99.1

Temporary Restraining Order - August 7, 2017

Exhibit 99.5

Forced Leave of Absence Notice to Starkman - April 19, 2017

Exhibit 99.7

Amendment to Temporary Restraining Order - Sep-12-2017

Exhibit 99.6

Letter from Securities and Exchange Commission to Company - August 22, 2017

Exhibit 99.9

KLEAN Letter of Intent

Exhibit 99.8

HADV / Health Advance Inc NT 10-Q

NT 10-Q 1 hadvnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N

Board Resolution - June 6, 2017

Exhibit 99.2

Temporary Restraining Order from U.S. Court, Wyoming District Against Jordan Starkman - August 7, 2017

Exhibit 99.5

Letter of Resignation Undersigned by Jordan Starkman - November 1, 2017

jordan starkman resignation letter.tif Exhibit 99.1

HADV / Health Advance Inc 8-K/A (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission

Forced Leave of Absence Notice to Jordan - April 19, 2017

Exhibit 99.7

Board Resolution - December 12, 2017

Exhibit 99.4

Board Resolution - June 30, 2017

Exhibit 99.3

Amendment to Temporary Restraining Order from U.S. Court, Wyoming District - Health Advance v. Starkman - September 12, 2017

Exhibit 99.6

Temporary Restraining Order from U.S. Court, Wyoming District Against Jordan Starkman - August 7, 2017

Exhibit 99.5

Forced Leave of Absence Notice to Jordan - April 19, 2017

Exhibit 99.7

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission Fil

Board Resolution - December 12, 2017

Exhibit 99.4

Forced Leave of Absence Notice to Jordan - April 19, 2017

Exhibit 99.7

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission Fi

Temporary Restraining Order from U.S. Court, Wyoming District Against Jordan Starkman - August 7, 2017

Exhibit 99.5

HADV / Health Advance Inc 8-K/A (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission Fil

HADV / Health Advance Inc 8-K (Current Report)

Microsoft Word - Health Advance 8-K November 7, 2017 - Draft for Review v4.docx UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 33

EX-99.1

Exhibit 99.1

Quarterly Report - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122

EX-99.2

Exhibit 99.2

EX-99.3

Exhibit 99.3

EX-99.1

Exhibit 99.1

EX-99.1

Exhibit 99.1

EX-99.2

Exhibit 99.2

Quarterly Report - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE INC

Health Advance 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission File

EX-99.2

Exhibit 99.2

EX-99.1

Exhibit 99.1

Quarterly Report - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE I

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission

Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs

Exhibit 99.3 Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs LAS VEGAS, January 17, 2017 ? Health Advance Inc. (the ?Company?) (OTC Pinks: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement (?Agreement?) to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as ?Hantian?). As a result of the acquisition, He

Health Advance NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response?????????... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: January 3

EX-99.1

Health Advance Acquires Licensing Rights to Patent Pending Product Formulations Containing Cannabis, Kava, & Kratom Extracts LAS VEGAS, NV – March 7, 2017 - Health Advance, Inc.

Health Advance FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2017 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Commission File

EX-10.1

Exhibit 10.1

Health Advance Acquires Licensing Rights to Patent Pending Product Formulations Containing Cannabis, Kava, & Kratom Extracts

Exhibit 99.1 Health Advance Acquires Licensing Rights to Patent Pending Product Formulations Containing Cannabis, Kava, & Kratom Extracts LAS VEGAS, March 7, 2017 /CNW/ - Health Advance, Inc. (OTC PINK: HADV) enters into a material definitive agreement with Micro Medtech, Ltd. for exclusive licensing rights in North America to cebidiofen and polyoxyfen, two patent-pending product formulations for

Quarterly Report - AMENDMENT NO 1 ON FORM 10-Q

Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended October 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2016 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Com

Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs

Blueprint Exhibit 99.1 Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs LAS VEGAS, January 17, 2017 – Health Advance Inc. (the “Company”) (OTC Pinks: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement (“Agreement”) to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as “Hantian”). As a result of the acqui

ARTICLE I INTERPRETATION

Blueprint Exhibit 10.1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT is made effective the 13th day of October, 2016. BETWEEN: HEALTH ADVANCE INC.,?a corporation existing under the laws of the State of Wyoming (hereinafter referred to as ?Health Advance? or the ?Purchaser?) - and - HANTIAN LABS LIMITED.?a corporation existing under the laws of the United Kingdom (hereinafter referred to a

Quarterly Report - QUARTERLY REPORT

Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended October 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH

Health Advance ANNUAL REPORT (Annual Report)

Blueprint SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact name of regi

Health Advance 12B-25

Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response...2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ? Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period Ended: July 31, 2016 ?

ARTICLE I INTERPRETATION

Blueprint Exhibit 10.1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT is made effective the 13th day of October, 2016. BETWEEN: HEALTH ADVANCE INC.,?a corporation existing under the laws of the State of Wyoming (hereinafter referred to as ?Health Advance? or the ?Purchaser?) - and - HANTIAN LABS LIMITED.?a corporation existing under the laws of the United Kingdom (hereinafter referred to a

Health Advance CURRENT REPORT (Current Report/Significant Event)

Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2016 HEALTH ADVANCE INC. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or other jurisdiction of incorporation) (Com

Health Advance Inc. Announces Signing of Definitive Agreement to Acquire Hantian Labs

Blueprint Exhibit 99.1 Health Advance Inc. Announces Signing of Definitive Agreement to Acquire Hantian Labs LAS VEGAS, October 14, 2016 ? Health Advance Inc. (the ?Company?) (OTC Pinks: HADV) is pleased to announce that on October 13, 2016, the Company signed a definitive agreement (?Definitive Agreement?) to acquire 100% interest in Hantian Labs Limited, a private UK corporation (Hereinafter ref

Health Advance QUARTERLY REPORT (Quarterly Report)

hadv10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2016 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH

Health Advance LATE NOTIFICATION FOR 10Q

hadvnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response?????????... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ?Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period Ended: Ap

Health Advance FORM 10-Q (Quarterly Report)

hadv2015123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177

Health Advance FORM NT 10-Q

hadv20151215nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response?????????... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ?Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended October 31, 2015 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE

Health Advance Form 10-Q (Quarterly Report)

hadv2015121910q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ?? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended October 31, 2015 or ?? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-1

Health Advance FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ☐Form 10-K ☐Form 20-F ☐Form 11-K ☒Form 10-Q ☐Form 10-D ☐Form N-SAR ☐Form N-CSR For Period Ended: October 31, 2015

Health Advance Form NT 10-Q

hadv20151215nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response?????????... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ?Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period En

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact name of registrant as

Health Advance FORM NT 10-K

hadv20151029nt10k.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.C. 20549 Expires: October 31, 2018 FORM 12b-25 Estimated average burden hours per response?????????... 2.50 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ? Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period

Health Advance Form NT 10-K

hadv20151029nt10k.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.C. 20549 Expires: October 31, 2018 FORM 12b-25 Estimated average burden hours per response?????????... 2.50 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ?Form 10-K ?Form 20-F ?Form 11-K ? Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE INC

LETTER

April 14, 2015 Jordan Starkman Chief Executive Officer Health Advance Inc. 3651 Linden Rd., Suite D155 Las Vegas, NV 89103 Re: Health Advance Inc. Form 10-K for the Fiscal Year Ended July 31, 2014 Filed November 12, 2014 File No. 333-177122 Dear Mr. Starkman: We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not for

Health Advance ESP

Health Advance Inc. 3651 Linden Road, Suite D155 Las Vegas, NV 89103 April 6, 2015 VIA EDGAR Jennifer Thompson, Accounting Branch Chief Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Amendment No. 1 to Form 10-K for the Fiscal Year Ended July 31, 2014 Filed March 20, 2015 Response dated March 20, 2015 File No. 333-177122 Dear Ms. Thompso

LETTER

April 2, 2015 Jordan Starkman Chief Executive Officer Health Advance Inc. 3651 Linden Rd., Suite D155 Las Vegas, NV 89103 Re: Health Advance Inc. Amendment No. 1 to Form 10-K for the Fiscal Year Ended July 31, 2014 Filed March 20, 2015 Response dated March 20, 2015 File No. 333-177122 Dear Mr. Starkman: We have reviewed your March 20, 2015 response to our comment letter and have the following comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE I

Health Advance ESP

Health Advance Inc. 3651 Linden Road, Suite D155 Las Vegas, NV 89103 March 20, 2015 VIA EDGAR Jennifer Thompson, Accounting Branch Chief Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Health Advance Inc. Form 10-K for the Fiscal Year Ended July 31, 2014 Filed on November 12, 2014 File No. 333-177122 Dear Ms. Thompson: We are in recei

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2014 o TRANSITION REPORT PURSUANT TO SEC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact na

Health Advance FILING EXTENSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response?????????... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: January 31

LETTER

March 12, 2015 Jordan Starkman Chief Executive Officer Health Advance Inc. 3651 Linden Rd., Suite D155 Las Vegas, NV 89103 Re: Health Advance Inc. Form 10-K for the Fiscal Year Ended July 31, 2014 Filed November 12, 2014 File No. 333-177122 Dear Mr. Starkman: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. In our comment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended October 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE I

HADV / Health Advance Inc NT 10-Q - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: October 31

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact name of registrant as

HADV / Health Advance Inc NT 10-K - -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response…………………….2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ý Form 10-K  Form 20-F  Form 11-K ¨Form 10-Q  Form 10-D  Form N-SAR  Form N-CSR For Period Ended: July 31, 2014 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2014 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH ADVANCE I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended October 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALT

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 8, 2013 Health Advance, Inc. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or Other Jurisdiction (Commission File (IRS Employer

December 9, 2013

Exhibit 16.1 December 9, 2013 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 U.S.A. Dear Sirs/Madams: Re: Health Advance, Inc. We are the former independent auditors for Health Advance, Inc. (the “Company”). We have read the Company’s disclosure in the section “Changes in Registrant’s Certifying Accountant” as included in Section 4.01 of the Company’s 8-K dated December 8

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact name of reg

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALTH

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: April 30,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 333-177122 HEALT

- QUARTERLY REPORT EXTENSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): oForm 10-K o Form 20-F o Form 11-K ý Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2013 o T

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2013 Health Advance, Inc. (Exact name of registrant as specified in its charter) Wyoming 333-177122 46-0525223 (State or Other Jurisdiction (Commission File (IRS Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTH ADVANCE INC. (Exact name of registrant as speci

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): oForm 10-K o Form 20-F o Form 11-K ý Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: October 31, 2012 o T

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 O

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-177122 HEALTH ADVANCE INC. (Exact name of reg

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ý Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July 31, 2012 o Tr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTH ADVANCE INC. (Exact name of registrant as specifi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTH ADVANCE INC. (Exact name of registrant as speci

- FORM 10Q EXTENSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-177122 CUSIP NUMBER (Check one): ¨ Form 10-K o Form 20-F o Form 11-K ý Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2012 o T

-

Health Advance, Inc. 3651 Lindell Road, Suite #D155 Las Vegas, NV 89103 January 24, 2012 U.S. Securities & Exchange Commission Office of Small Business 100 F Street, NE Washington, D.C. 20549 Re: Health Advance, Inc. File No. 333-177122 Dear Sir/Madam: Request is hereby made for the acceleration of the effective date of our Registration Statement on Form S-1, File No. 333-177122, to 12:00 P.M. Eas

-

January 17, 2012 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549-4631 Re: Health Advance Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed January 3, 2012 File No. 333-177122 Dear Charles Lee: We represent Health Advance, Inc. (“Health Advance” or, the “Company,” “we,” “us,” or “our”). By letter dated January 12, 2012 the

- FORM S-1/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ================================== AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ================================== Health Advance Inc. (Exact Name of registrant as specified in its charter) Wyoming (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial

LETTER

January 12, 2012 Via E-mail Jordan Starkman President Health Advance Inc. 3651 Lindell Road, Suite #D155 Las Vegas, NV 89103 Re: Health Advance Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed January 3, 2012 File No. 333-177122 Dear Mr. Starkman: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with

-

January 3, 2012 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549-4631 Re: Health Advance Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 9, 2011 File No. 333-177122 Dear Charles Lee: We represent Health Advance, Inc. (“Health Advance” or, the “Company,” “we,” “us,” or “our”). By letter dated December 20, 2011 the

- FORM S-1/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ================================== AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ================================== Health Advance Inc. (Exact Name of registrant as specified in its charter) Wyoming (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial

LETTER

December 20, 2011 Via E-mail Jordan Starkman President Health Advance Inc. 3651 Lindell Road, Suite #D155 Las Vegas, NV 89103 Re: Health Advance Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 9, 2011 File No. 333-177122 Dear Mr. Starkman: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us wi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact Name of registrant as specified in its charter) (State or other jur

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ================================== AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ================================== Health Advance Inc. (Exact Name of registrant as specified in its charter) Wyoming (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial

-

December 9, 2011 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549-4631 Re: Health Advance Inc. Registration Statement on Form S-1 Filed September 30, 2011 File No. 333-177122 Dear Charles Lee: We represent Health Advance, Inc. (“Health Advance” or, the “Company,” “we,” “us,” or “our”). By letter dated October 24, 2011 the staff (the “Staf

LETTER

October 24, 2011 Via E-mail Jordan Starkman President Health Advance Inc. 3651 Lindell Road, Suite #D155 Las Vegas, NV 89103 Re: Health Advance Inc. Registration Statement on Form S-1 Filed September 30, 2011 File No. 333-177122 Dear Mr. Starkman: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so

____________________ HEALTH ADVANCE, INC. ARTICLE I The Corporation

Exhibit 3.2 BY-LAWS OF HEALTH ADVANCE, INC. ARTICLE I The Corporation Section 1. Name. The legal name of this corporation (hereinafter called the “Corporation”) is Health Advance, Inc. Section 2. Offices. The Corporation shall have its principal office in the State of Wyoming. The Corporation may also have offices at such other places within and without the United States as the Board of Directors

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Health Advance Inc. (Exact Name of registrant as specified in its charter) (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ================================== FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ================================== Health Advance Inc. (Exact Name of registrant as specified in its charter) Wyoming (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Cod

STATE OF WYOMING

Exhibit 3.1 STATE OF WYOMING Office of the Secretary of State I, MAX MAXFIELD, SECRETARY OF STATE of the STATE OF WYOMING, do hereby certify that the filing requirements for the issuance of this certificate have been fulfilled. CERTIFICATE OF INCORPORATION Health Advance Inc. Accordingly, the undersigned, by virtue of the authority vested in me by the law, hereby issues this Certificate. I have af